Celiac disease;Maladie cœliaque

Revue de Medecine Interne

Volumn 31, Issue 6, 2010, Pages 428-433

  Malamut, G ^a,b   Cellier, C ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Anti tissue transglutaminase antibodies; Celiac disease; Guten free diet; Lymphoma; Osteopenia

Indexed keywords

GLUTEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; BIOLOGICAL MARKER; HLA DQ ANTIGEN; HLA DQ2 ANTIGEN, HUMAN; HLA-DQ2 ANTIGEN, HUMAN;

ADENOCARCINOMA; AMENORRHEA; ANEMIA; ANTIBODY BLOOD LEVEL; APHTHOUS STOMATITIS; CELIAC DISEASE; CLINICAL FEATURE; DISEASE PREDISPOSITION; ENTEROPATHY; EUROPE; FOOD INTAKE; GLUTEN FREE DIET; HISTOLOGY; HUMAN; INTESTINE VILLUS ATROPHY; LYMPHOMA; OSTEOPENIA; PREVALENCE; SHORT SURVEY; UNITED STATES; ADULT; ARTHRITIS; ARTICLE; BLOOD; CHILD; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; FEMALE; IMMUNOLOGY; INTESTINE MUCOSA; PATHOLOGY; PROGNOSIS; SMALL INTESTINE;

ADULT; AMENORRHEA; ANEMIA; ARTHRITIS; BIOLOGICAL MARKERS; CELIAC DISEASE; CHILD; DIAGNOSIS, DIFFERENTIAL; DIET, GLUTEN-FREE; FEMALE; HLA-DQ ANTIGENS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; PROGNOSIS; STOMATITIS, APHTHOUS;

EID: 77953539608     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.04.009     Document Type: Short Survey

References (62)

1. Sollid L.M., Lie B.A. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005, 3:843-851.
2. Farrell R.J., Kelly C.P. Celiac sprue. N Engl J Med 2002, 346:180-188.
3. Matysiak-Budnik T., Candalh C., Dugave C., Namane A., Cellier C., Cerf-Bensussan N., et al. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology 2003, 125:696-707.
4. Lundin K.E., Scott H., Hansen T., Paulsen G., Halstensen T.S., Fausa O., et al. Gliadin-specific, HLA-DQ (alpha 1*0501, beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993, 178:187-196.
5. Nilsen E.M., Jahnsen F.L., Lundin K.E., Johansen F.E., Fausa O., Sollid L.M., et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998, 115:551-563.
6. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E.O., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997, 3:797-801.
7. Mention J.J., Ben Ahmed M., Begue B., Barbe U., Verkarre V., Asnafi V., et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003, 125:730-745.
8. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004, 21:357-366.
9. Green P.H., Cellier C. Celiac disease. N Engl J Med 2007, 357:1731-1743.
10. Maki M., Mustalahti K., Kokkonen J., Kulmala P., Haapalahti M., Karttunen T., et al. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003, 348:2517-2524.
11. Fasano A., Berti I., Gerarduzzi T., Not T., Colletti R.B., Drago S., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003, 163:286-292.
12. Catassi C., Ratsch I.M., Gandolfi L., Pratesi R., Fabiani E., El Asmar R., et al. Why is coeliac disease endemic in the people of the Sahara?. Lancet 1999, 354:647-648.
13. Catassi C. Age at gluten introduction and risk of Celiac disease (CD): a prospective, multicentre, nutritional intervention study on infants at family CD risk Gastroenterology 2008;134:A211.
14. Rampertab S.D., Pooran N., Brar P., Singh P., Green P.H. Trends in the presentation of celiac disease. Am J Med 2006, 119:355e9-14.
15. Murray J.A., Van Dyke C., Plevak M.F., Dierkhising R.A., Zinsmeister A.R., Melton L.J. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol 2003, 1:19-27.
16. Trivin F., Cellier C. Diagnosis of symptom-free celiac disease in a patient with persistent hypertransaminasemia of obscur origin. Gastroenterol Clin Biol 2001, 25:553-554.
17. Kaukinen K., Halme L., Collin P., Farkkila M., Maki M., Vehmanen P., et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology 2002, 122:881-888.
18. Wahnschaffe U., Ullrich R., Riecken E.O., Schulzke J.D. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001, 121:1329-1338.
19. Nuti R., Martini G., Valenti R., Giovani S., Salvadori S., Avanzati A. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med 2001, 250:361-366.
20. Vasquez H., Mazure R., Gonzalez D., Flores D., Pedreira S., Niveloni S., et al. Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol 2000, 95:183-189.
21. Jafri M.R., Nordstrom C.W., Murray J.A., Van Dyke C.T., Dierkhising R.A., Zinsmeister A.R., et al. Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota. Dig Dis Sci 2008, 53:964-971.
22. Luostarinen L.K., Collin P.O., Peraaho M.J., Maki M.J., Pirttila T.A. Coeliac disease in patients with cerebellar ataxia of unknown origin. Ann Med 2001, 33:445-449.
23. Audia S., Duchêne C., Samson M., Muller G., Bielefeld P., Ricolfi F., et al. Accident vasculaire cérébral ischémique de l'adulte jeune au cours de la maladie cœliaque. À propos de deux observations. Rev Med Interne 2008, 29:228-231.
24. De Bem R.S., Da Ro Sa Utiyama S.R., Nisihara R.M., Fortunato J.A., Tondo J.A., Carmes E.R., et al. Celiac disease prevalence in Brazilian dilated cardiomyopathy patients. Dig Dis Sci 2006, 51:1016-1019.
25. Martinelli P., Troncone R., Paparo F., Torre P., Trapanese E., Fasano C., et al. Coeliac disease and unfavourable outcome of pregnancy. Gut 2000, 46:332-335.
26. Liu E., Rewers M., Eisenbarth G.S. Genetic testing: who should do the testing and what is the role of genetic testing in the setting of celiac disease?. Gastroenterology 2005, 128:S33-S37.
27. Zone J.J. Skin manifestations of celiac disease. Gastroenterology 2005, 128:S87-91.
28. Di Sabatino A., Pickard K.M., Gordon J.N., Salvati V., Mazzarella G., Beattie R.M., et al. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 2007, 133:1175-1187.
29. Hill I.D. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?. Gastroenterology 2005, 128:S25-32.
30. Wong R.C., Wilson R.J., Steele R.H., Radford-Smith G., Adelstein S. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 2002, 55:488-494.
31. Connon J.J., McFarland J., Kelly A., Biggart J.D., McLoughlin J. Acute abdominal complications of coeliac disease. Scand J Gastroenterol 1975, 10:843-846.
32. Niveloni S., Sugai E., Cabanne A., Vazquez H., Argonz J., Smecuol E., et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem 2007, 53:2186-2192.
33. Liu E., Li M., Emery L., Taki I., Barriga K., Tiberti C., et al. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr 2007, 45:293-300.
34. Ocmant A., Mascart F. Effective detection of celiac disease using salivary anti-transglutaminase. Am J Med 2007, 120:e15. [author reply e17].
35. De Chaisemartin L., Malamut G., Cellier C., Dragon-Durey M. Evaluation of a whole blood-based rapid test for IgA anti-transglutaminase detection in celiac disease. Gastroenterology 2008, 134 A:214.
36. Marsh M. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunologic approach to the spectrum of gluten sensitivity (celiac sprue). Gastroenterology 1992, 102:330-354.
37. Bai J.C., Gonzalez D., Mautalen C., Mazure R., Pedreira S., Vazquez H., et al. Long-term effect of gluten restriction on bone mineral density of patients with coeliac disease. Aliment Pharmacol Ther 1997, 11:157-164.
38. Cellier C., Flobert C., Cormier C., Roux C., Schmitz J. Severe osteopenia in symptom-free adults with a childhood diagnosis of coeliac disease. Lancet 2000, 355:806.
39. Ventura A., Magazzu G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP study group for autoimmune disorders in celiac disease. Gastroenterology 1999, 117:297-303.
40. Fotoulaki M., Nousia-Arvanitakis S., Augoustidou-Savvopoulou P., Kanakoudi-Tsakalides F., Zaramboukas T., Vlachonikolis J. Clinical application of immunological markers as monitoring tests in celiac disease. Dig Dis Sci 1999, 44:2133-2138.
41. Lee S.K., Lo W., Memeo L., Rotterdam H., Green P.H. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc 2003, 57:187-191.
42. Holmes G.K., Prior P., Lane M.R., Pope D., Allan R.N. Malignancy in coeliac disease. Effect of a gluten free diet. Gut 1989, 30:333-338.
43. Cosnes J., Cellier C., Viola S., Colombel J.F., Michaud L., Sarles J., et al. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 2008, 6:753-758.
44. Vahedi K., Mascart F., Mary J.Y., Laberenne J.E., Bouhnik Y., Morin M.C., et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003, 98:1079-1087.
45. Béchade D., Carmoi T., Bonnefoy S., Blondon H., Desramé J., Algayres J.P. Association d'une colite lymphocytaire à une maladie cœliaque probablement déclenchée par la prise de venlafaxine (Effexor). Rev Med Interne 2009, 30:74-77.
46. Fine K.D., Meyer R.L., Lee E.L. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology 1997, 112:1830-1838.
47. Cellier C., Delabesse E., Helmer C., Patey N., Matuchansky C., Jabri B., et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000, 356:203-208.
48. Gass J., Bethune M.T., Siegel M., Spencer A., Khosla C. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology 2007, 133:472-480.
49. Stenman S., Lindfors K., Venalainen J., Mannisto P., Kaukinen K., Makki M. Proteases from germinating wheat decrease the toxic effects of celiac disease-inducing wheat gliadin. Gastroenterology 2008, 134. A-80.
50. Leffler D.A., Kelly C., Paterson B., Abdullah H., Collatrela A., Murray J. A randomized, double-blind study of AT-1001 for the prevention of celiac disease activation with gluten challenge. Gastroenterology 2008, 134. A-80.
51. Cellier C., Patey N., Mauvieux L., Jabri B., Delabesse E., Cervoni J.P., et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998, 114:471-481.
52. Al-Toma A., Verbeek W.H., Hadithi M., von Blomberg B.M., Mulder C.J. Survival in refractory coeliac disease and enteropathy associated T cell Lymphoma: Retrospective evaluation of single centre experience. Gut 2007, 56:1373-1378.
53. Malamut G., Afchain P., Verkarre V., Lecomte T., Amiot A., Damotte D., et al. Presentation and long term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009, 136:81-90.
54. Al-Toma A., Visser O.J., van Roessel H.M., von Blomberg B.M., Verbeek W.H., Scholten P.E., et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T-cells. Blood 2007, 109:2243-2249.
55. Askling J., Linet M., Gridley G., Halstensen T.S., Ekstrom K., Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002, 123:1428-1435.
56. Hoffmann M., Vogelsang H., Kletter K., Zettinig G., Chott A., Raderer M. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Gut 2003, 52:347-351.
57. Egan L.J., Walsh S.V., Stevens F.M., Connolly C.E., Egan E.L., McCarthy C.F. Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol 1995, 21:123-129.
58. Howdle P.D., Jalal P.K., Holmes G.K., Houlston R.S. Primary small-bowel malignancy in the UK and its association with celiac disease. QJM 2003, 96:345-353.
59. Green P.H., Fleischauer A.T., Bhagat G., Goyal R., Jabri B., Neugut A.I. Risk of malignancy in patients with celiac disease. Am J Med 2003, 115:191-195.
60. Rampertab S.D., Forde K.A., Green P.H. Small bowel neoplasia in coeliac disease. Gut 2003, 52:1211-1214.
61. Corrao G., Corazza G.R., Bagnardi V., Brusco G., Ciacci C., Cottone M., et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001, 358:356-361.
62. Malamut G., Cellier C. Celiac disease: mass screening or diagnosis in high risk populations?. Gastroenterol Clin Biol 2004, 28:863-867.